delee - Delee General Information Description Operator of shoud a technology company intended to specialize in biotech and medical device automation The companys technology enables the performance of a CirculatingTumourCells CTC Bloodbased assay that has the potential to be used for early cancer detection and monitoring of the applied treatments effectiveness this technology consists of an Inicio Delee Corp Delee Corp offers a digital slide scanner that can scan digitize and view slide specimens with various staining techniques The device has a flexible LED illumination system a dual camera multiple magnifications and unattended scans Liza Velarde Delees CEO was preparing the agenda for the companys 2025 planning in November 2020 The journey has been challenging and Liza Velarde faced critical decisionmaking milestones Delee transforming cancer detection and treatment ResearchGate Delee Y Combinator Delee is a company that develops CytoCatch a device for isolating and analyzing circulating tumor cells from blood samples The case study explores the challenges and opportunities of its business model intellectual property and time to market Cytocatch Imaging System Delee Corp Delee transforming cancer detection and treatment At Delee we created The CytoCath our product insignia that automatically processes a blood sample 10 mL in less than 20 mins and isolates the Circulating Tumor Cells with over 96 capture efficiency After the isolation it gives the option to do the analyzes with our designed Delee kode pos jorong tanah laut Corp is a medical device company that offers a screening test for cancer therapy management and a technology for isolating and analyzing circulating tumor cells CTCs Learn how the CytoCatch platform can capture classify enumerate and molecularly analyze CTCs with high efficiency and reproducibility Delee Corp LinkedIn Delee is a San Franciscobased startup that develops CytoCatch a technology that isolates and analyzes circulating tumor cells CTCs from blood samples The company aims to revolutionize how cancer is diagnosed and managed with its patentpending platform and imaging system Delee Corp is a biotechnology research company that develops devices for isolating and analyzing CTCs from patient blood samples The company aims to enable early detection and personalized treatment of cancer with its CytoCatch platform and imaging system Delee Company Profile 2025 Valuation Funding Investors PitchBook Cytocatch Isolation Platform Delee Corp PDF Nextgeneration cancer diagnostics and treatment monitoring CoFounder and acting CEO at Delee Corp Velarde has been responsible for the development and execution of the companys strategic plans Velardes outstanding work has been highly regarded by international institutions such as Cartier Womens Initiative Awards and WeXchange from the InterAmerican Development Bank Delee Corp offers a device to isolate circulating tumor cells CTCs from blood samples without antibodies or preenrichment The platform is fully automated labelfree and compatible with various downstream applications Delee hiasan dinding angka kelas tk Crunchbase Company Profile Funding
fsdss 731
angka sandi morse
